The George Washington University is a private federally chartered research university in Washington, D.C. Chartered in 1821 by the United States Congress, GWU is the largest institution of higher education in the District of Columbia.

During the past decade, George Washington University conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 27 clinical trials were completed, i.e. on average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 20 clinical trials were completed. i.e. 60.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "George Washington University" #1 sponsor was "George Washington University" with 18 trials, followed by "NICHD Neonatal Research Network" with 14 trials sponsored, "AstraZeneca" with 4 trials sponsored, "International AIDS Vaccine Initiative" with 4 trials sponsored and "University of Pennsylvania" with 4 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "George Washington University" #1 collaborator was "George Washington University" with 15 trials as a collaborator, "National Center for Research Resources (NCRR)" with 12 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 6 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials as a collaborator and "National Institutes of Health (NIH)" with 4 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 102 trials.

According to Clinical.Site data, the most researched conditions in "George Washington University" are "Infant, Newborn" (14 trials), "Infant, Low Birth Weight" (12 trials), "Infant, Premature" (12 trials), "Infant, Small for Gestational Age" (12 trials) and "HIV Infections" (10 trials). Many other conditions were trialed in "George Washington University" in a lesser frequency.

Most popular intervention types in "George Washington University" are "Drug" (63 trials), "Device" (18 trials), "Other" (18 trials), "Behavioral" (17 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "AC2993" (4 trials), "Blood Collection" (2 trials), "Early Cord Clamping" (2 trials) and "Umbilical Cord Milking" (2 trials). Other intervention names were less common.

The vast majority of trials in "George Washington University" are 133 trials for "All" genders, 10 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 37 active trials in "George Washington University". 1 are not yet recruiting, 24 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 88 completed trials in George Washington University, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in George Washington University, 15 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 38 trials that are defined as “Not Applicable".

George Washington University has several departments that took part in Clinical trials: "George Washington University Cancer Center" - 3 trials, "George Washington University Department of Dermatology" - 2 trials, "The George Washington University, Department of Emergency Medicine" - 2 trials, "The George Washington University, Department of Health, Human Function and Rehabilitation Science" - 2 trials